• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, December 22, 2023

News
Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A study titled “Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes,” published in the December 2023 issue of The American Journal of Managed Care® (AJMC®), was referenced in articles from Physician’s Weekly, DocWire News, and HCPLive. The study found that approximately 40% of patients with type 2 diabetes discontinued their second-line therapies within a year.

An article from Medriva referenced an article published on AJMC.com, the website of AJMC. The article, “Top 5 Conference Coverage of 2023,” collected the most-viewed items on AJMC.com that reported on new research presented at medical conferences that AJMC editors attended throughout the year, including the Annual Meeting of the American Society of Clinical Oncology and the European Hematology Association Congress.

Related Videos
1 expert is featured in this series.
5 experts are featured in this series.
Dawn Klemow, MD, assistant clinical professor, The University of Texas Southwestern Medical Center
1 expert is featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.